The world might be facing turmoil and uncertainty — states that Novavax Inc. knows all too well — but today, the Gaithersburg biotech has reason to celebrate. The company has reported positive results for its late-stage clinical trial of seasonal flu vaccine NanoFlu, marking its first successful phase 3 study after two devastating failures. These latest results now open an otherwise impenetrable door with a product candidate viewed as Novavax’s last best chance for success — and its first-ever…
from https://www.bizjournals.com/baltimore/news/2020/03/24/novavax-s-seasonal-flu-vaccine-just-got-great-news.html?ana=RSS&s=article_search
via https://baltimorecheckbook.tumblr.com/post/613477091379445760
No comments:
Post a Comment